InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: fuagf post# 368955

Wednesday, 03/31/2021 9:02:07 AM

Wednesday, March 31, 2021 9:02:07 AM

Post# of 480976

AstraZeneca and Pfizer coronavirus vaccines should be deferred for small group of Australians amid blood clot concerns, advisory group says



They propose deferring an Adeno vector, and a mRNA vaccine. Those 2 classes covers almost all of the "genetic" vaccines! Although the AZN vaccine has the most problems. Including its efficacy against the variants especially in 65+.

Here's another

article

Note the percentages being discussed (e.g. 17/20M+).

Now compare to literature discussing CVST in Covid infections

Linky

Hematologic effects of SARS-CoV-2 infection have been increasingly recognized and documented in recent literature. An atypically high incidence of venous thromboembolism (VTE) has been reported ranging from 7.7 to 28.0% in patients hospitalized with COVID-19 associated pneumonia even with appropriate VTE prophylaxis



and more percentages


The individual's choice seems to be the usual:

1. Take the vaccine (e.g. mRNA), and risk you will be one of the <1% lucky ones to develop an autoimmune condition resulting in blood clots.

or

2. Don't get vaccinated. In which case one hopes not to get a Covid infection with a 7-28% chance of blood clots.

Thus far it's background noise for the vaccines. For now they might want to monitor those already with an autoimmune disease, or have increased co-morbidity risk for blood clots, abnormalities in the platelets.

There are the protein or non-genetic based (e.g. NVAX), vaccines yet to be approved, that could be used in high risk individuals, or if the problem increases with future booster shots. But even the more traditional vaccines can cause these autoimmune reactions.


The Jewel of the Mind is Colored with the Hue of what it Imagines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.